Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Brainsway Ltd ADR (BWAY)

Brainsway Ltd ADR (BWAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 182,057
  • Shares Outstanding, K 18,827
  • Annual Sales, $ 41,020 K
  • Annual Income, $ 2,920 K
  • EBIT $ 1 M
  • EBITDA $ 3 M
  • 60-Month Beta 1.29
  • Price/Sales 4.48
  • Price/Cash Flow 39.79
  • Price/Book 2.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.02
  • Number of Estimates 3
  • High Estimate 0.03
  • Low Estimate 0.01
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.88 +7.59%
on 03/07/25
10.54 -9.39%
on 03/12/25
-0.20 (-2.05%)
since 02/26/25
3-Month
8.88 +7.59%
on 03/07/25
11.79 -19.00%
on 02/18/25
+0.18 (+1.92%)
since 12/26/24
52-Week
4.61 +107.16%
on 04/18/24
11.79 -19.00%
on 02/18/25
+4.10 (+75.23%)
since 03/26/24

Most Recent Stories

More News
Zacks.com featured highlights include SB Financial Group, First Community, StoneX Group, Byrna Technologies and BrainsWay

For Immediate ReleaseChicago, IL – February 14, 2025 – Stocks in this week’s article are — SB Financial Group Inc. SBFG, First Community Corp. FCCO, StoneX Group Inc. SNEX, Byrna Technologies Inc....

BWAY : 9.49 (-1.86%)
SBFG : 21.00 (-0.79%)
SNEX : 79.52 (-2.56%)
FCCO : 22.44 (-0.93%)
BYRN : 17.75 (-3.48%)
5 Stocks With Recent Price Strength to Enhance Your Portfolio

U.S. stock markets witnessed an impressive rally in 2024 after an astonishing bull run in 2023. Despite fluctuations, the bull run continued in 2025. Market participants remained concerned about the Trump...

BWAY : 9.49 (-1.86%)
SBFG : 21.00 (-0.79%)
SNEX : 79.52 (-2.56%)
FCCO : 22.44 (-0.93%)
BYRN : 17.75 (-3.48%)
Zacks.com featured highlights include Bridgewater Bancshares, Eastern Bankshares and BrainsWay

For Immediate ReleaseChicago, IL – February 7, 2025 – Stocks in this week’s article are — Bridgewater Bancshares, Inc. BWB, Eastern Bankshares, Inc. EBC and BrainsWay Ltd. BWAY.3 Top-Ranked Breakout...

BWAY : 9.49 (-1.86%)
EBC : 16.77 (+0.06%)
BWB : 13.94 (+1.38%)
Zacks.com featured highlights include Mission Produce, Accel Entertainment, BrainsWay and First Bank

For Immediate ReleaseChicago, IL – February 7, 2025 – Stocks in this week’s article are — Mission Produce, Inc. AVO, Accel Entertainment Inc. ACEL, BrainsWay, Ltd. BWAY and First Bank FRBA.4 Top-Ranked...

BWAY : 9.49 (-1.86%)
ACEL : 10.16 (+0.40%)
FRBA : 14.86 (+0.13%)
AVO : 9.90 (+1.12%)
4 Top-Ranked Solid Net Profit Margin Stocks to Boost Portfolio Returns

Net profit, also referred to as the bottom line, is one of the key tools to determine the financial health of an enterprise. The metric demonstrates a company’s ability to convert per-dollar sales into...

BWAY : 9.49 (-1.86%)
ACEL : 10.16 (+0.40%)
FRBA : 14.86 (+0.13%)
AVO : 9.90 (+1.12%)
3 Top-Ranked Breakout Stocks to Buy Now: BWB, EBC, BWAY

Searching for breakout stocks within a specific price band is an active investing strategy. Consider selling if the price falls below the lower band and holding for gains if it exceeds the upper band when...

BWAY : 9.49 (-1.86%)
EBC : 16.77 (+0.06%)
BWB : 13.94 (+1.38%)
Outbrain (OB) and Brainsway (BWAY) Are Aggressive Growth Stocks

As the aggressive growth stock strategist at Zacks Investment Research Brian Bolan usually looks for stocks that have a strong Zacks Style Score for Growth and a weak Style Score for Value. This week he...

BWAY : 9.49 (-1.86%)
OB : 3.97 (-3.41%)
New Strong Buy Stocks for January 14th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Brainsway BWAY: This commercial stage medical device company which is focused on the development and sale of non-invasive neuromodulation...

TV : 1.8050 (-1.37%)
BWAY : 9.49 (-1.86%)
SBH : 8.81 (+1.73%)
PHIN : 45.72 (+0.66%)
ICUI : 148.36 (-1.01%)
Zacks.com featured highlights include Byrna Technologies, Idaho Strategic Resources, Limbach Holdings, Sezzle and BrainsWay

For Immediate ReleaseChicago, IL – September 19, 2024 – Stocks in this week’s article are Byrna Technologies Inc. BYRN, Idaho Strategic Resources Inc. IDR, Limbach Holdings Inc. LMB, Sezzle Inc....

LMB : 80.16 (-2.18%)
BWAY : 9.49 (-1.86%)
BYRN : 17.75 (-3.48%)
IDR : 13.42 (-3.73%)
SEZL : 232.04 (-7.37%)
5 Stocks With Recent Price Strength to Enhance Your Portfolio

The September syndrome is already visible in U.S. stock markets. Known as the worst-performing month for Wall Street, the situation remains challenging this year, too. Major stock indexes suffered significant...

LMB : 80.16 (-2.18%)
BWAY : 9.49 (-1.86%)
BYRN : 17.75 (-3.48%)
IDR : 13.42 (-3.73%)
SEZL : 232.04 (-7.37%)

Business Summary

BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder....

See More

Key Turning Points

3rd Resistance Point 10.06
2nd Resistance Point 9.98
1st Resistance Point 9.82
Last Price 9.49
1st Support Level 9.59
2nd Support Level 9.51
3rd Support Level 9.35

See More

52-Week High 11.79
Last Price 9.49
Fibonacci 61.8% 9.05
Fibonacci 50% 8.20
Fibonacci 38.2% 7.35
52-Week Low 4.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar